For instance, Akt inhibitors suppress p66Shc phosphorylation, thereby reducing ROS production and PD‐L1 upregulation and sensitising tumours to immune checkpoint inhibitors (ICIs) like anti‐PD‐1/PD‐L1 [194]. The gene discussed is AKT1; the disease is neoplasm.